share_log

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga ·  Sep 13, 2023 09:06

Gainers

  • Avalo Therapeutics (NASDAQ:AVTX) shares rose 73.8% to $0.21 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.3 million.
  • Rocket Pharmaceuticals (NASDAQ:RCKT) stock rose 37.01% to $20.95. The company's market cap stands at $1.6 billion.
  • ZyVersa Therapeutics (NASDAQ:ZVSA) stock moved upwards by 26.53% to $0.16. The company's market cap stands at $5.0 million.
  • Axcella Health (NASDAQ:AXLA) stock moved upwards by 21.49% to $1.39. The market value of their outstanding shares is at $102.0 million.
  • Hoth Therapeutics (NASDAQ:HOTH) shares moved upwards by 18.28% to $3.17. The market value of their outstanding shares is at $10.4 million.
  • Tenon Medical (NASDAQ:TNON) stock rose 17.06% to $0.21. The market value of their outstanding shares is at $4.7 million.

Losers

  • Eiger BioPharmaceuticals (NASDAQ:EIGR) shares decreased by 33.3% to $0.46 during Wednesday's pre-market session. The company's market cap stands at $20.3 million.
  • Infinity Pharmaceuticals (NASDAQ:INFI) stock declined by 16.97% to $0.07. The market value of their outstanding shares is at $6.3 million.
  • Sana Biotechnology (NASDAQ:SANA) shares declined by 12.13% to $5.0. The market value of their outstanding shares is at $984.7 million.
  • OKYO Pharma (NASDAQ:OKYO) shares fell 11.92% to $1.7. The market value of their outstanding shares is at $43.4 million.
  • Nuwellis (NASDAQ:NUWE) stock decreased by 10.91% to $1.47. The market value of their outstanding shares is at $2.7 million.
  • Baudax Bio (NASDAQ:BXRX) shares declined by 10.62% to $0.33. The company's market cap stands at $3.0 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment